In comparison, the recurring immunophenotypic features of blasts/blast equivalents in AML with NPM1 mutation include the presence of some admixed monocytes and a prominent CD11c population, and some expression of HLA-DR and/or CD15. This evidence concerns the gene ITGAX and acute myeloid leukemia.